These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 24698717)

  • 1. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].
    Pons I; Espinosa G; Cervera R
    Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
    Erkan D; Vega J; Ramón G; Kozora E; Lockshin MD
    Arthritis Rheum; 2013 Feb; 65(2):464-71. PubMed ID: 23124321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.
    Rymarz A; Niemczyk S
    BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of antiphospholipid syndrome in pregnancy.
    Cowchock S
    Lupus; 1998; 7 Suppl 2():S95-7. PubMed ID: 9814682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
    Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
    Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature.
    Erre GL; Pardini S; Faedda R; Passiu G
    Lupus; 2008 Jan; 17(1):50-5. PubMed ID: 18089684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of antiphospholipid syndrome with intravenous immunoglobulin in addition to conventional therapy.
    Tenti S; Guidelli GM; Bellisai F; Galeazzi M; Fioravanti A
    Clin Exp Rheumatol; 2013; 31(6):877-82. PubMed ID: 23985161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].
    Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.
    Espinosa G; Bucciarelli S; Cervera R; Lozano M; Reverter JC; de la Red G; Gil V; Ingelmo M; Font J; Asherson RA
    Ann Rheum Dis; 2004 Jun; 63(6):730-6. PubMed ID: 15140782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.
    Ruffatti A; De Silvestro G; Marson P; Tonello M; Calligaro A; Favaro M; Del Ross T; Hoxha A; Mattia E; Pengo V
    J Autoimmun; 2018 Sep; 93():124-130. PubMed ID: 30146007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
    Khamashta MA
    Lupus; 1998; 7 Suppl 2():S162-5. PubMed ID: 9814696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.